Durham, NC, United States of America

Douglas Weitzel

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Douglas Weitzel: Innovator in Cancer Treatment

Introduction

Douglas Weitzel is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of cancer treatment. With a total of three patents to his name, Weitzel has focused on developing innovative methods and compounds that target various forms of cancer.

Latest Patents

Weitzel's latest patents include "Kinase inhibitors and related methods of use," which is directed towards compounds that selectively inhibit Death Associated Protein Kinases (DAPKs) and PIM kinases. These compounds have potential applications in treating various disorders, including cancers. Another notable patent is "Synergistic nanotherapy systems and methods of use thereof," which outlines a method for treating cancer, particularly metastatic bladder and breast cancer. This method involves using a combination of plasmonics-active metal nanoparticles and photon radiation to effectively target primary and secondary tumor cells.

Career Highlights

Throughout his career, Douglas Weitzel has worked with esteemed institutions such as Duke University and Uti Limited Partnership. His work has been instrumental in advancing cancer treatment methodologies, showcasing his dedication to improving patient outcomes.

Collaborations

Weitzel has collaborated with notable colleagues, including Timothy A. J. Haystead and David A. Carlson, further enhancing the impact of his research and innovations in the field.

Conclusion

Douglas Weitzel's innovative work in cancer treatment through his patents and collaborations highlights his commitment to advancing medical science. His contributions are paving the way for more effective cancer therapies, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…